CoChat

A Novel Non-Digestible, Carrot-Derived Polysaccharide (cRG-I) Selectively Modulates the Human Gut Microbiota while Promoting Gut Barrier Integrity: An Integrated In Vitro Approach

Open access
Van den Abbeele, Pieter, Verstrepen, Lynn, Ghyselinck, Jonas, Albers, Ruud, Marzorati, Massimo, Mercenier, Annick · 2020 · Nutrients

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Abstract

Modulation of the gut microbiome as a means to improve human health has recently gained increasing interest. In this study, it was investigated whether cRG-I, a carrot-derived pectic polysaccharide, enriched in rhamnogalacturonan-I (RG-I) classifies as a potential prebiotic ingredient using novel in vitro models. First, digestion methods involving α-amylase/brush border enzymes demonstrated the non-digestibility of cRG-I by host-derived enzymes versus digestible (starch/maltose) and non-digestible controls (inulin). Then, a recently developed short-term (48 h) colonic incubation strategy was applied and revealed that cRG-I fermentation increased levels of health-promoting short-chain fatty acids (SCFA; mainly acetate and propionate) and lactate comparable but not identical to the reference prebiotic inulin. Upon upgrading this fermentation model by inclusion of a simulated mucosal environment while applying quantitative 16S-targeted Illumina sequencing, cRG-I was additionally shown to specifically stimulate operational taxonomic units (OTUs) related to health-associated species such as Bifidobacterium longum, Bifidobacterium adolescentis, Bacteroides dorei, Bacteroides ovatus, Roseburia hominis, Faecalibacterium prausnitzii, and Eubacterium hallii. Finally, in a novel model to assess host–microbe interactions (Caco-2/peripheral blood mononuclear cells (PBMC) co-culture) fermented cRG-I increased barrier integrity while decreasing markers for inflammation. In conclusion, by using novel in vitro models, cRG-I was identified as a promising prebiotic candidate to proceed to clinical studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu12071917

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation of the integrated in vitro approach to investigate the prebiotic potential of cRG-I (carrot-derived rhamnogalacturonan-I). First, potential digestion of cRG-I by amylase/brush border enzymes was investigated (Test 1). In Test 2, short-term colonic batch incubations were used to assess the prebiotic potential on microbial metabolic activity of cRG-I compared to inulin. In Test 3, the prebiotic potential of two formulations that differed in absence (cRG-I) or presence of low molecular weight carbohydrates (cRG-I+LMWC) was assessed in both conventional luminal incubations (L) and incubations including a mucosal compartment (M). Samples were collected to evaluate the effect of the test products on microbial activity, community composition and on intestinal permeability and immunity (Test 4, Caco-2/PBMC co-culture model).
Figure 1 Schematic representation of the integrated in vitro approach to investigate the prebiotic potential of cRG-I (carrot-derived rhamnogalacturonan-I). First, potential digestion of cRG-I by amylase/brush border enzymes was investigated (Test 1). In Test 2, short-term colonic batch incubations were used to assess the prebiotic potential on microbial metabolic activity of cRG-I compared to inulin. In Test 3, the prebiotic potential of two formulations that differed in absence (cRG-I) or presence of low molecular weight carbohydrates (cRG-I+LMWC) was assessed in both conventional luminal incubations (L) and incubations including a mucosal compartment (M). Samples were collected to evaluate the effect of the test products on microbial activity, community composition and on intestinal permeability and immunity (Test 4, Caco-2/PBMC co-culture model).CC BY · PubMed Central
Figure 2 Digestion of cRG-I (carrot-derived rhamnogalacturonan-I) by amylase (A) and brush border enzymes (B) versus inulin, cooked starch, and maltose. Blank incubations containing all reagents in absence of a substrate were included. Average (± st. dev.) concentrations of different monosaccharides and maltose were measured by High Performance Anion Exchange Chromatography (HPAEC) (n = 3).
Figure 2 Digestion of cRG-I (carrot-derived rhamnogalacturonan-I) by amylase (A) and brush border enzymes (B) versus inulin, cooked starch, and maltose. Blank incubations containing all reagents in absence of a substrate were included. Average (± st. dev.) concentrations of different monosaccharides and maltose were measured by High Performance Anion Exchange Chromatography (HPAEC) (n = 3).CC BY · PubMed Central
Figure 3 Effect of fermentation of cRG-I on microbial metabolic activity in short-term colonic incubations. Average changes (± st. dev.) in pH (A), gas production (B), total short-chain fatty acids (SCFA) (C), acetate (D), propionate (E), butyrate (F), branched CFA (bCFA) (G) and lactate (H) levels between 0 and 6 h (light gray), 6 h and 24 h (dark gray) and 24 h and 48 h (stripes) upon dosing cRG-I and inulin to the gut microbiota versus a blank incubation (n = 3). Statistically significant differences between blank and treatments for different time intervals are presented by * for Δ0 h–6 h, $ for Δ6 h–24 h or # for Δ24 h–48 h. (*, $, #) = p < 0.05, (**, $$, ##) = p < 0.01, (***, $$$, ###) = p < 0.001 and (****, $$$$, ####) = p < 0.0001.
Figure 3 Effect of fermentation of cRG-I on microbial metabolic activity in short-term colonic incubations. Average changes (± st. dev.) in pH (A), gas production (B), total short-chain fatty acids (SCFA) (C), acetate (D), propionate (E), butyrate (F), branched CFA (bCFA) (G) and lactate (H) levels between 0 and 6 h (light gray), 6 h and 24 h (dark gray) and 24 h and 48 h (stripes) upon dosing cRG-I and inulin to the gut microbiota versus a blank incubation (n = 3). Statistically significant differences between blank and treatments for different time intervals are presented by * for Δ0 h–6 h, $ for Δ6 h–24 h or # for Δ24 h–48 h. (*, $, #) = p < 0.05, (**, $$, ##) = p < 0.01, (***, $$$, ###) = p < 0.001 and (****, $$$$, ####) = p < 0.0001.CC BY · PubMed Central
Figure 4 Effect of fermentation of cRG-I and cRG-I+LMWC on microbial metabolic activity in short-term colonic batch simulations in absence or presence of a mucosal compartment. Average changes (± st. dev.) in pH (A), gas production (B), total short-chain fatty acids (SCFA) (C), acetate (D), propionate (E), butyrate (F), branched CFA (bCFA) (G) and lactate (H) levels between 0 and 6 h (light gray), 6 h and 24 h (dark gray) and 24 h and 48 h (stripes) upon dosing cRG-I and cRG-I + LMWC to the gut microbiota versus a blank incubation (n = 3). Statistically significant differences between the blank and treatments for different time intervals are presented by * for Δ0 h–6 h, $ for Δ6 h–24 h or # for Δ24 h–48 h). (*, $, #) = p < 0.05, (**, $$, ##) = p < 0.01, (***, $$$, ###) = p < 0.001 and (****, $$$$, ####) = p < 0.0001. L = colonic incubations only simulating lumen; M = incubations simulating both lumen and mucus.
Figure 4 Effect of fermentation of cRG-I and cRG-I+LMWC on microbial metabolic activity in short-term colonic batch simulations in absence or presence of a mucosal compartment. Average changes (± st. dev.) in pH (A), gas production (B), total short-chain fatty acids (SCFA) (C), acetate (D), propionate (E), butyrate (F), branched CFA (bCFA) (G) and lactate (H) levels between 0 and 6 h (light gray), 6 h and 24 h (dark gray) and 24 h and 48 h (stripes) upon dosing cRG-I and cRG-I + LMWC to the gut microbiota versus a blank incubation (n = 3). Statistically significant differences between the blank and treatments for different time intervals are presented by * for Δ0 h–6 h, $ for Δ6 h–24 h or # for Δ24 h–48 h). (*, $, #) = p < 0.05, (**, $$, ##) = p < 0.01, (***, $$$, ###) = p < 0.001 and (****, $$$$, ####) = p < 0.0001. L = colonic incubations only simulating lumen; M = incubations simulating both lumen and mucus.CC BY · PubMed Central
Figure 5 Effect of fermentation of cRG-I and cRG-I+LMWC on microbial community composition at phylum level in short-term colonic incubations in absence or presence of a mucosal compartment. Average (± st. dev.) proportional (%) (A) and absolute (16S gene copies/mL) (B) abundance of the different phyla in the original (diluted) inoculum (INO) and after 48 h of incubation upon dosing of cRG-I and cRG-I+LMWC versus a blank control (n = 3). Statistically significant differences between the blank and treatments are presented by *. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001 and (****) = p < 0.0001. L = colonic incubations only simulating lumen; M = incubations simulating both lumen and mucus.
Figure 5 Effect of fermentation of cRG-I and cRG-I+LMWC on microbial community composition at phylum level in short-term colonic incubations in absence or presence of a mucosal compartment. Average (± st. dev.) proportional (%) (A) and absolute (16S gene copies/mL) (B) abundance of the different phyla in the original (diluted) inoculum (INO) and after 48 h of incubation upon dosing of cRG-I and cRG-I+LMWC versus a blank control (n = 3). Statistically significant differences between the blank and treatments are presented by *. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001 and (****) = p < 0.0001. L = colonic incubations only simulating lumen; M = incubations simulating both lumen and mucus.CC BY · PubMed Central
Figure 6 Effect of fermented cRG-I on transepithelial electrical resistance (TEER) and cytokine production in a Caco-2/PBMC co-culture system. Caco-2 cells, cultured 14 days on transwell inserts, were placed on top of pokeweed mitogen (PWM)-activated PBMCs and incubated for 48 h at the apical side with blank or treatment samples collected during the colonic batch incubations containing only a luminal (L) or also a mucosal (M) environment. Average (±SEM) TEER of the Caco-2 monolayers (A) and concentration of secreted interferon (IFN)γ (B), interleukin (IL)-17A (C), IL-21 (D), IL-22 (E), IL-4 (F), IL-9 (G) and IL-10 (H) in the basolateral medium are shown (n = 3). Statistically significant differences to PWM are represented by (*). (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001.
Figure 6 Effect of fermented cRG-I on transepithelial electrical resistance (TEER) and cytokine production in a Caco-2/PBMC co-culture system. Caco-2 cells, cultured 14 days on transwell inserts, were placed on top of pokeweed mitogen (PWM)-activated PBMCs and incubated for 48 h at the apical side with blank or treatment samples collected during the colonic batch incubations containing only a luminal (L) or also a mucosal (M) environment. Average (±SEM) TEER of the Caco-2 monolayers (A) and concentration of secreted interferon (IFN)γ (B), interleukin (IL)-17A (C), IL-21 (D), IL-22 (E), IL-4 (F), IL-9 (G) and IL-10 (H) in the basolateral medium are shown (n = 3). Statistically significant differences to PWM are represented by (*). (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Coenen, 2007, Identification of the connecting linkage between homo- or xylogalacturonan and rhamnogalacturonan type I. Carbohydrate, Polymers, 70, 224

Cited by

See all 76

Metadata

Authors
Van den Abbeele, P., Verstrepen, L., Ghyselinck, J., Albers, R., Marzorati, M., & Mercenier, A.
Affiliations
  • ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium
  • ProDigest (Belgium) (BE)
  • NutriLeads (Netherlands) (NL)
  • Ghent University (BE)
Corresponding author
Mercenier, Annick
Venue
Nutrients
Publisher
MDPI AG
Published
2020-06-29
Volume
12
Issue
7
Pages
1917
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3037033850
Cited by
73
References
82
Citations by year
2026: 5 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 11 · 2021: 10 · 2020: 2
FWCI
6.63
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Horizon 2020 (SMEi 811592)
  • European Commission (Eurostars E! 10574-NIMF)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
rhamnogalacturonan I, prebiotics, gut microbiota modulation, short-chain fatty acids, colonic fermentation, Bifidobacterium, Faecalibacterium prausnitzii, intestinal barrier integrity, inflammation, inulin
MeSH terms
Gastrointestinal Microbiome, Host Microbial Interactions, Bifidobacterium, Colon, Digestion, Fermentation, Humans, Intestinal Mucosa, Pectins, Electric Impedance, Daucus carota, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.